9.99

15.84% -1.88

After Hours: 9.92 -0.07 -0.70%

Cogent Biosciences Inc (COGT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cogent Biosciences Inc stock is traded at $9.99, with a volume of 5.29M. It is down -15.84% in the last 24 hours and down -10.08% over the past month. Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.

Previous Close:

$11.87

Open:

$11.84

24h Volume:

5.29M

Relative Volume:

5.44

Market Cap:

$1.09B

Revenue:

Net Income/Loss:

$-227.05M

P/E Ratio:

-4.5409

EPS:

-2.2

Net Cash Flow:

$-177.93M

1W Performance:

-16.75%

1M Performance:

-10.08%

6M Performance:

+32.67%

1Y Performance:

+17.39%

1-Day Range:

$9.3702

$11.98

1-Week Range:

$9.3702

$12.30

52-Week Range:

$3.67

$12.61

Cogent Biosciences Inc Stock (COGT) Company Profile

Name

Cogent Biosciences Inc

Sector

Healthcare (1181)

Industry

Biotechnology (671)

Phone

617-945-5576

Address

275 WYMAN STREET, WALTHAM

Employee

164

Twitter

Next Earnings Date

2024-10-31

Latest SEC Filings

COGT's Discussions on Twitter

Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-24	Downgrade	Robert W. Baird	Outperform → Neutral
Feb-08-24	Initiated	Citigroup	Buy
Dec-11-23	Downgrade	Wedbush	Outperform → Neutral
Dec-08-23	Initiated	JP Morgan	Overweight
Apr-28-23	Initiated	Robert W. Baird	Outperform
Mar-27-23	Resumed	H.C. Wainwright	Buy
Dec-14-22	Initiated	Needham	Buy
Jun-28-22	Initiated	Guggenheim	Buy
Oct-11-21	Initiated	H.C. Wainwright	Buy
Jun-09-21	Resumed	Jefferies	Buy
Dec-23-20	Initiated	Piper Sandler	Overweight
Oct-14-20	Initiated	Ladenburg Thalmann	Buy

View All

Cogent Biosciences Inc Stock (COGT) Latest News

02:34 AM

Cogent Biosciences (NASDAQ:COGT) Shares Down 5.3%What's Next? - MarketBeat

02:34 AM

09:11 AM

Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting - The Manila Times

09:11 AM

09:00 AM

Cogent Biosciences to Present Key Bezuclastinib Trial Data at ASH 2024 Meeting | COGT Stock News - StockTitan

09:00 AM

Nov 04, 2024

Cogent Biosciences' (COGT) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 04, 2024

Nov 03, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.67 Average PT from Brokerages - Defense World

Nov 03, 2024

Oct 31, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 31, 2024

Oct 26, 2024

(COGT) Investment Analysis - Stock Traders Daily

Oct 26, 2024

Hennion & Walsh Asset Management Inc. Purchases 44,287 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Oct 26, 2024

Oct 24, 2024

Cogent Biosciences' (COGT) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Oct 24, 2024

Oct 23, 2024

Cogent Biosciences expands pipeline with KRAS inhibitor - Investing.com

Oct 23, 2024

Cogent Biosciences expands pipeline with KRAS inhibitor By Investing.com - Investing.com UK

Oct 23, 2024

Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics - StockTitan

Oct 23, 2024

Cogent Biosciences Announces Pipeline Expansion into KRAS - GlobeNewswire

Oct 23, 2024

COGT Stock Hits 52-Week High at $12.2 Amid Market Optimism - Investing.com India

Oct 23, 2024

Oct 22, 2024

Cogent Biosciences (NASDAQ:COGT) Sets New 52-Week HighHere's What Happened - MarketBeat

Oct 22, 2024

Oct 20, 2024

Here's Why We're Not Too Worried About Cogent Biosciences' (NASDAQ:COGT) Cash Burn Situation - Yahoo Finance

Oct 20, 2024

Oct 19, 2024

SG Americas Securities LLC Acquires New Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Oct 19, 2024

Oct 18, 2024

The Manufacturers Life Insurance Company Has $301,000 Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Oct 18, 2024

Oct 17, 2024

Market Momentum Report: Cogent Biosciences Inc (COGT)’s Negative Close at 11.35 - The Dwinnex

Oct 17, 2024

Oct 16, 2024

Cogent Biosciences (NASDAQ:COGT) Shares Down 2.4%What's Next? - MarketBeat

Oct 16, 2024

Oct 15, 2024

(COGT) Technical Data - Stock Traders Daily

Oct 15, 2024

Oct 14, 2024

Stocks of Cogent Biosciences Inc (COGT) are poised to climb above their peers - SETE News

Oct 14, 2024

Oct 10, 2024

Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.6%Here's What Happened - MarketBeat

Oct 10, 2024

Oct 09, 2024

Did Cogent Biosciences Inc (COGT) perform well in the last session? - US Post News

Oct 09, 2024

Analysts Rate Cogent Biosciences, Inc. (COGT) as Moderate Buy with $15 Target - Insider Monkey

Oct 09, 2024

Oct 08, 2024

Get in on Cogent Biosciences Inc’s (COGT) buy-in window today! - SETE News

Oct 08, 2024

Metric Deep Dive: Understanding Cogent Biosciences Inc (COGT) Through its Ratios - The Dwinnex

Oct 08, 2024

Dimensional Fund Advisors LP Has $7.84 Million Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Oct 08, 2024

Oct 06, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Oct 06, 2024

Oct 04, 2024

(COGT) On The My Stocks Page - Stock Traders Daily

Oct 04, 2024

American Century Companies Inc. Sells 7,032 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Oct 04, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Algert Global LLC - Defense World

Oct 04, 2024

Algert Global LLC Sells 207,078 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Oct 04, 2024

Oct 01, 2024

Cogent Biosciences (NASDAQ:COGT) Shares Down 4.2% - MarketBeat

Oct 01, 2024

A better buy-in window may exist right now for Cogent Biosciences Inc (COGT) - SETE News

Oct 01, 2024

Can Cogent Biosciences Inc (COGT) meet market expectations this quarter? - US Post News

Oct 01, 2024

Insider’s View: Deciphering Cogent Biosciences Inc (COGT)’s Financial Health Through Ratios - The Dwinnex

Oct 01, 2024

Sep 30, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Short Interest Update - Defense World

Sep 30, 2024

Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by SkyView Investment Advisors LLC - Defense World

Sep 30, 2024

Cogent Biosciences: Need To Wait For More Data For Adequate Differentiation (NASDAQ:COGT) - Seeking Alpha

Sep 30, 2024

Point72 Asset Management L.P. Has $88.27 Million Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Sep 30, 2024

Sep 29, 2024

Forefront Analytics LLC Sells 3,648 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Sep 29, 2024

Sep 28, 2024

Profund Advisors LLC Sells 73,992 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Sep 28, 2024

Sep 26, 2024

It makes sense and dollars to buy Cogent Biosciences Inc (COGT) stock - SETE News

Sep 26, 2024

Deerfield Management Company L.P. Series C Grows Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Sep 26, 2024

Sep 25, 2024